CHERYL GEE-MAURER: Open Payments
NPI 1003684630 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$839 in 24 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $685 · 2025 $839
Food & beverage: $839
| Company | Payments | Amount |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | 1 | $126 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Gilead Sciences, Inc. | 2 | $98 |
| Tempus AI, Inc | 1 | $70 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 3 | $66 |
| Janssen Biotech, Inc. | 2 | $53 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
Products named: ZEPZELCA, OPDIVO, Trodelvy, XT CDX, Enhertu, Nubeqa, KEYTRUDA, PLUVICTO.
Industry payments across PA — which companies pay providers there.
